☀️     🌓

Prescribing Advice for GPs

An NHS Prescribing Advisers' Blog

Drug Safety Update, Issue 12

The Medicines and Healthcare products Regulatory Agency (MHRA) has published Drug Safety Update Issue 12 (PDF).

This issue includes the following drug safety advice articles:

  • Varenicline: suicidal thoughts and behaviour
  • Bisphosphonates: atrial fibrillation

In addition, this issue contains a hot topic containing information about
inhaled products that contain corticosteroids. This section contains several reminders for clinicians including consideration of the licensed indication for steroid inhalers, spacer devices and brand name prescribing for CFC-free beclometasone.

Action: Clinicians will find this publication to be a useful review of current issues in drug safety.

Share 'Drug Safety Update, Issue 12' by emailShare 'Drug Safety Update, Issue 12' on FacebookShare 'Drug Safety Update, Issue 12' on TwitterShare 'Drug Safety Update, Issue 12' on LinkedInShare 'Drug Safety Update, Issue 12' on reddit


No Comments to “Drug Safety Update, Issue 12”

Leave a Comment

Your email address will not be published. Required fields are marked *

Please be aware that you comment is subject to our Privacy Policy.

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Prescribing Advice for GPs is powered by ClassicPress.
Connect to our RSS or Atom Feeds.